Immunology Week 10

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/111

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 10:19 AM on 4/22/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

112 Terms

1
New cards

What are the main types of lymphocytes?

B cells; CD4+ helper T cells; CD8+ cytotoxic T cells; Natural killer (NK) cells

2
New cards

What is the main function of CD8+ T cells?

Recognize antigens on MHC I and kill cancer cells via perforin and granzymes, inducing apoptosis

3
New cards

What molecules do cytotoxic T cells use to kill target cells?

Perforin and granzymes

4
New cards

What is the role of MHC class I in cancer immunity?

Presents tumour antigens to CD8+ T cells for recognition

5
New cards

Why are T-cell therapies less effective in solid tumours?

Poor trafficking, lack of ideal antigens, and immunosuppressive tumour microenvironment

6
New cards

What are the steps in CAR-T cell therapy?

Extract T cells → genetically modify with CAR → expand → reinfuse into patient

7
New cards

Why is CAR-T therapy effective in blood cancers?

Cancer cells are more accessible and lack complex physical/immunosuppressive barriers

8
New cards

Why is CAR-T therapy less effective in solid tumours?

TME barriers, antigen heterogeneity, poor infiltration, immunosuppression

9
New cards

What is the tumour microenvironment (TME)?

A complex system of cancer cells, immune cells, ECM, vasculature, and stromal cells

10
New cards

What is a key feature of the TME?

It is heterogeneous and actively suppresses immune responses

11
New cards

How do tumours use immune cells in the TME?

Recruit and convert them into tumour-supporting “bodyguards”

12
New cards

What causes hypoxia in tumours?

Rapid growth outpaces blood supply

13
New cards

What is the effect of hypoxia in tumours?

Creates a dead core and reduces T-cell survival

14
New cards

How does ECM affect T-cell function?

Acts as a physical barrier preventing infiltration

15
New cards

What is abnormal about tumour vasculature?

Leaky, disorganized, impairs immune cell trafficking

16
New cards

What is the effect of low chemokines in TME?

Reduced immune signalling and T-cell activation

17
New cards

How do CD8+ T cells recognise tumour cells?

TCR binds tumour antigen presented on MHC I

18
New cards

What is T-cell infiltration?

Movement of T cells into tumour tissue

19
New cards

Why is T-cell infiltration difficult in solid tumours?

Physical barriers, hypoxia, abnormal vasculature, low chemokines

20
New cards

What is T-cell exhaustion?

Dysfunctional state due to chronic stimulation with reduced cytokine production and activity

21
New cards

What cytokines decrease in exhausted T cells?

IL-2, IFN-γ, TNF-α

22
New cards

What is T-cell anergy?

State of unresponsiveness where T cells cannot activate even if antigen is recognised

23
New cards

What is metabolic competition in TME?

Tumour consumes nutrients and oxygen, starving T cells

24
New cards

What is tumour antigen heterogeneity?

Tumour cells express different antigens, making targeting difficult

25
New cards

What is antigen escape?

Tumour cells lose or alter antigens to avoid immune recognition

26
New cards

What cytokines do tumours release to suppress immunity?

IL-10 and TGF-β

27
New cards

What is CSF-1 role in tumours?

Recruits tumour-associated macrophages (TAMs)

28
New cards

What is the role of STAT3 in tumours?

Promotes immunosuppression, angiogenesis, and tumour growth

29
New cards

How does hypoxia affect signalling pathways?

Increases VEGF and activates STAT3

30
New cards

What is VEGF?

Vascular endothelial growth factor that promotes abnormal blood vessel formation

31
New cards

How do tumours reduce antigen presentation?

Downregulate MHC expression

32
New cards

What are immune checkpoints?

Regulatory proteins that prevent autoimmunity by inhibiting T-cell activation

33
New cards

What are key immune checkpoints in cancer?

PD-1, PD-L1, CTLA-4

34
New cards

How do tumours use immune checkpoints?

Upregulate checkpoint ligands to suppress T cells

35
New cards

What are immune checkpoint inhibitors (ICIs)?

Drugs that block checkpoint interactions and restore T-cell activity

36
New cards

What are the three categories of tumour immune evasion?

Antigen loss, T-cell inhibition, immunosuppressive environment

37
New cards

What is the role of Tregs in tumours?

Suppress T-cell responses

38
New cards

What are MDSCs?

Myeloid-derived suppressor cells that inhibit anti-tumour immunity

39
New cards

What is tumour immune evasion?

Process by which tumours avoid immune detection and destruction

40
New cards

What are general inflammation pathways in cancer therapy?

Strategies that activate immune responses via cytokines or antibodies

41
New cards

What is ADCC?

Antibody-dependent cell-mediated cytotoxicity

42
New cards

What is CCL21 role in therapy?

Recruits lymphocytes and dendritic cells to tumour

43
New cards

What are nanoparticle therapies?

Delivery systems that improve stability and targeting of drugs/cytokines

44
New cards

What is TIL therapy?

Extraction, expansion, and reinfusion of tumour-infiltrating lymphocytes

45
New cards

How does CAR-T therapy cause toxicity?

Can attack healthy tissues (off-tumour toxicity)

46
New cards

What is antigen heterogeneity problem in CAR-T?

Different tumour cells express different targets

47
New cards

What are next-generation CAR-T improvements?

Better specificity, persistence, reduced toxicity

48
New cards

What is combination immunotherapy?

Using multiple treatments (e.g. CAR-T + ICIs) to improve outcomes

49
New cards

What is TME modulation?

Altering tumour environment to enhance immune function

50
New cards

What is CCR5 role in CAR-T therapy?

Improves T-cell migration into tumours

51
New cards

What is IL-12 role in CAR-T therapy?

Enhances T-cell activity and counteracts immunosuppression

52
New cards

Why combine CCR5 and IL-12?

Improves both infiltration and function of T cells

53
New cards

What are main challenges in solid tumour therapy?

Poor infiltration, antigen variability, immunosuppression, toxicity

54
New cards

What is the best strategy for treating solid tumours?

Combination therapies targeting multiple mechanisms

55
New cards

What is the key takeaway about T cells in solid tumours?

They are effective but suppressed by the tumour environment

56
New cards
What is the main focus of Lecture 2?
Imaging T-cell function and tracking T-cell behaviour in tumours
57
New cards
Why is imaging T cells important in cancer therapy?
To track location, infiltration, and persistence and evaluate therapy effectiveness
58
New cards
What are the key challenges in imaging T cells in solid tumours?
Dense structure, heterogeneity, and difficulty visualising infiltration
59
New cards
What are the three main challenges for T cells in the TME?
Physical barriers, T-cell dysfunction/exhaustion, antigen heterogeneity
60
New cards
What is meant by T-cell infiltration?
Movement of T cells into tumour tissue
61
New cards
Why is T-cell infiltration difficult in solid tumours?
Dense ECM, abnormal vasculature, and immunosuppressive environment
62
New cards
What is T-cell exhaustion?
Dysfunctional state with reduced responsiveness due to chronic stimulation
63
New cards
What is T-cell anergy?
Severe dysfunction where T cells become unresponsive ("inactive state")
64
New cards
What is tumour antigen heterogeneity?
Variation in antigen expression across tumour cells
65
New cards
Why does antigen heterogeneity limit therapy?
Makes it difficult to target all tumour cells with one strategy
66
New cards
What is the purpose of cell labelling in imaging?
To track cells in vitro and in vivo using fluorescence
67
New cards
What is fluorescence in cell imaging?
Emission of light after absorption of energy by π-conjugated systems
68
New cards
What are non-covalent dyes?
Dyes that bind weakly (e.g. membrane insertion) and can move or be lost over time
69
New cards
What are membrane dyes used for?
Insert into lipid bilayer to label and track cells
70
New cards
What are Vybrant dyes?
Long-chain carbocyanine dyes that insert into membranes for cell tracking
71
New cards
What are key features of Vybrant dyes?
Non-covalent, low cytotoxicity, transferable during cell division
72
New cards
How long can Vybrant dyes track cells?
Approximately 2–3 days
73
New cards
What is a limitation of non-covalent dyes?
Signal loss over time due to diffusion and cell division
74
New cards
What is Hoechst 33342 used for?
Nuclear staining in live cells
75
New cards
How does Hoechst dye work?
Binds to AT-rich regions in DNA minor groove and fluoresces
76
New cards
What is a limitation of Hoechst dye?
Can cause DNA damage and fluorescence decreases over time
77
New cards
What is the difference between Hoechst and DAPI?
Hoechst is cell-permeable (live cells), DAPI requires fixed cells
78
New cards
What are BODIPY dyes used for?
Organelle imaging and probes (e.g. Golgi, lysosomes)
79
New cards
What are advantages of BODIPY dyes?
High fluorescence, tunable properties, photostability
80
New cards
What is a limitation of BODIPY dyes?
Poor long-term retention and not transferred to daughter cells
81
New cards
What is covalent labelling?
Stable attachment of dyes to cellular proteins via chemical bonds
82
New cards
Why use covalent labelling?
Long-term retention and tracking across cell generations
83
New cards
What is maleimide labelling?
Covalent binding to thiol groups (cysteine residues)
84
New cards
What is NHS ester labelling?
Covalent binding to primary amines (lysine residues)
85
New cards
What is a disadvantage of covalent labelling?
Potential cytotoxicity and non-specific binding
86
New cards
What are CFSE and CFDA-SE dyes used for?
Tracking cell proliferation
87
New cards
How does CFSE track cell division?
Fluorescence halves with each cell division
88
New cards
What is CFDA-SE?
A non-fluorescent precursor activated inside cells
89
New cards
What is metabolic glycan labelling?
Labelling cells via incorporation of modified sugars into glycoproteins
90
New cards
What molecule is used in metabolic glycan labelling?
Ac4ManNAz (azide-modified sugar)
91
New cards
What reaction is used in glycan labelling?
Click chemistry (SPAAC reaction)
92
New cards
What is an advantage of metabolic glycan labelling?
More specific and less cytotoxic than protein labelling
93
New cards
What is a limitation of glycan labelling?
Signal decreases over 72–96 hours
94
New cards
What is flow cytometry?
Technique to measure physical and fluorescent properties of cells in flow
95
New cards
What does forward scatter (FSC) measure?
Cell size
96
New cards
What does side scatter (SSC) measure?
Cell complexity/granularity
97
New cards
What does flow cytometry measure in T-cell studies?
Fluorescence intensity, cell size, proliferation
98
New cards
How is proliferation tracked using flow cytometry?
Fluorescence intensity halves with each generation
99
New cards
What is confocal microscopy used for?
3D imaging of cells using optical sectioning (z-stacks)
100
New cards
What is an organoid model?
3D tumour model used to study T-cell infiltration and behaviour